信息搜索
信息关键字：药
  

共有3954条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]

·百丰医药2020年净利同比增长44.39%毛利率有所提升2021-3-26 22:12:19
·云南白药2020年度净利同比增长31.85%牙膏市场份额持续稳居全国第一2021-3-26 22:03:02
·云南白药：2020年净利同比增31.85%拟10转39元2021-3-26 19:55:55
·至信药业IPO：研发投入占比不足1%核心技术人员均为近三年内引入2021-3-26 19:30:45
·至信药业IPO：研发投入占比不足1%，核心技术人员均为近三年内引入2021-3-26 19:22:28
·贝达药业2020年净利162.7%董事长丁列明薪酬246.58万2021-3-26 19:18:24
·77股获机构买入型评级药石科技关注度最高2021-3-26 17:46:01
·奥翔药业：拟5000万元增资麒正药业有助于进一步推进其业务发展2021-3-26 17:42:00
·拓新药业、戎美股份将于4月2日创业板首发上会2021-3-26 16:47:39
·共同药业、恒帅股份、华绿生物、科美诊断3月29日申购2021-3-26 15:03:13
·现代制药2020年净利下滑1%：制剂业务下降董事长周斌薪酬209.5万2021-3-26 10:34:03
·贝达药业净利润猛增背后：大股东轮番套现29亿元单一药品局面难破2021-3-26 10:33:49
·药石科技2020年净利1.84亿增长21%：总经理董海军薪酬74万2021-3-26 9:01:25
·市场调整，私募转向？看好医药的林园重仓金龙鱼；冯柳、邓晓峰、庄涛重仓杀入这些股！2021-3-26 7:58:15
·郭美美被抓背后的减肥药市场乱象：违禁产品成本仅几元、副作用大2021-3-25 20:53:16
·违禁减肥药“添加剂”西布曲明：成本低、工艺简单，已被禁十余年2021-3-25 20:36:32
·振东制药2021年第一季度预计净利增长59%-88%朗迪钙收入增长2021-3-25 20:28:11
·新兴药业2020年净利减少13.87%受疫情影响降低2021-3-25 20:11:28
·基金经理节后密集调研医药、科技板块仍是重点“碳中和”概念受关注2021-3-25 10:18:42
·基金经理节后密集调研医药、科技板块仍是重点“碳中和”概念受关注2021-3-25 8:11:53

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]